Holmberg E, Maruyama K, Litzinger D C, Wright S, Davis M, Kabalka G W, Kennel S J, Huang L
Department of Biochemistry, University of Tennessee, Knoxville 37996.
Biochem Biophys Res Commun. 1989 Dec 29;165(3):1272-8. doi: 10.1016/0006-291x(89)92740-x.
Monoclonal antibody was conjugated to N-glutaryl-phosphatidylethanolamine in the presence of octylglucoside by using N-hydroxysulfosuccinimide as a carboxyl-activation reagent. The conjugated antibody was then incorporated into liposomes by a simple dialysis method. The method is mild and is compatible with various lipid compositions of the liposomes. We have prepared immunoliposomes containing a lung endothelium-specific monoclonal antibody and showed excellent target binding (approximately 75% injected dose) of the immunoliposomes in mouse. Immunoliposomes can be prepared to contain other acidic lipids such as phosphatidylserine and various amounts of cholesterol. The presence of 20% or more cholesterol in liposomes resulted in high level of target binding. We have used in these experiments a new radioactive lipid-phase marker, 111In-DTPA-SA, which was very stable in vivo. The halflife of clearance in mouse exceeded 3 weeks.
在辛基葡糖苷存在的情况下,使用N-羟基琥珀酰亚胺作为羧基活化试剂,将单克隆抗体与N-戊二酰磷脂酰乙醇胺偶联。然后通过简单的透析方法将偶联的抗体掺入脂质体中。该方法温和,并且与脂质体的各种脂质组成兼容。我们制备了含有肺内皮特异性单克隆抗体的免疫脂质体,并在小鼠中显示出免疫脂质体具有出色的靶向结合能力(约75%的注射剂量)。免疫脂质体可以制备成含有其他酸性脂质,如磷脂酰丝氨酸和各种量的胆固醇。脂质体中存在20%或更多的胆固醇会导致高水平的靶向结合。在这些实验中,我们使用了一种新的放射性脂质相标记物111In-DTPA-SA,它在体内非常稳定。在小鼠体内的清除半衰期超过3周。